SU764679A1 - Method of obtaining lysozyme solutions - Google Patents

Method of obtaining lysozyme solutions Download PDF

Info

Publication number
SU764679A1
SU764679A1 SU772553066A SU2553066A SU764679A1 SU 764679 A1 SU764679 A1 SU 764679A1 SU 772553066 A SU772553066 A SU 772553066A SU 2553066 A SU2553066 A SU 2553066A SU 764679 A1 SU764679 A1 SU 764679A1
Authority
SU
USSR - Soviet Union
Prior art keywords
solution
obtaining
lysozyme
pulsating
activity
Prior art date
Application number
SU772553066A
Other languages
Russian (ru)
Inventor
Станислав Алексеевич Гаврилов
Михаил Афанасьевич Костенко
Георгий Георгиевич Мордовской
Нина Николаевна Фролова
Маргарита Алексеевна Ударцева
Original Assignee
Свердловский Научно-Исследовательский Институт Туберкулеза
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Свердловский Научно-Исследовательский Институт Туберкулеза filed Critical Свердловский Научно-Исследовательский Институт Туберкулеза
Priority to SU772553066A priority Critical patent/SU764679A1/en
Application granted granted Critical
Publication of SU764679A1 publication Critical patent/SU764679A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Description

Изобретение относится к химикофармацевтической промышленности.The invention relates to the pharmaceutical industry.

Известен способ получения раствора лизоцима путем растворения сухого $ препата в изотонйческом растворе хлорида натрия или в растворе новокаина £1] .A known method of obtaining a solution of lysozyme by dissolving dry $ preparation in an isotonic sodium chloride solution or in a solution of novocaine £ 1].

Однако известный способ не обеспечивает высокой бактериологической активности.However, the known method does not provide high bacteriological activity.

Цель изобретения - повышение активности целевого продукта.The purpose of the invention is to increase the activity of the target product.

Поставленная цель достигается тем, что раствор лизоцима, полученный из- 15 вестньйа образом, обрабатывают'пульсирующим м&гнитным полем напряженностью 1800ί 800 Э в течение 100t 3.0 мин.This goal is achieved by the fact that the lysozyme solution obtained in a well-known manner is treated with a pulsating magnetic field of intensity 1800–800 Oe for 100t 3.0 min.

Способ поясняется следующим примером.The method is illustrated by the following example.

Пример. Содержимое флакона сухого лизоцима (150 мг) растворяют в 2-3 мп изотонического раствора хлорида натрия или в 0,25% растворе новокаина. Затем раствор обрабатывают пульсирующим магнитным полем напряженностью 1800 Э в течение 100 мин.Example. The contents of a bottle of dry lysozyme (150 mg) are dissolved in 2-3 mp isotonic sodium chloride solution or in 0.25% novocaine solution. Then the solution is treated with a pulsating magnetic field with a voltage of 1800 Oe for 100 minutes.

Сравнительные данные о бактериолитической активности полученного раствора лизоцима с известным представлены в таблице.Comparative data on the bacteriolytic activity of the obtained lysozyme solution with the known are presented in the table.

Использование изобретения позволяет на порядок повысить бактериолитическую активность раствора лизоцима и эффективность лечения инфекционных заболеваний и уменьшить количество лечебных доз лизоцима.The use of the invention allows to increase by an order of magnitude the bacteriolytic activity of the lysozyme solution and the effectiveness of the treatment of infectious diseases and reduce the number of therapeutic doses of lysozyme.

Способ получения раствора лизоцима и режим обработки его магнитным полем (МП) A method of obtaining a solution of lysozyme and the mode of processing it with a magnetic field (MP) Количестве опытов Number of experiments Средняя продолжительность воздействия : im, минAverage exposure time : im, min Средние величины бактериолитической активности раствора в % при следующих значениях его концентрации, мкг/мп The average bacteriolytic activity of the solution in% at the following values of its concentration, μg / mp 800 800 400 400 200 200 100 100 50 fifty 25 25 Без обработки МП : Without MP processing: 345 345 - - 100 100 50 fifty 25 25 0 0 0 0 0 0

С обработкой пульсирующимWith pulsating treatment

МП с напряженностьюMP with tension

1800 Э ’ 345 100 100 100 100 100 75 01800 E ’345 100 100 100 100 100 75 0

Claims (1)

Без обработки МП : 345 С обработкой пульсирующим МП с напр женностью : 1800 Э 345 Формула изобретени  Способ получени  раствора лиэоцима путем растворени  сухого прейарата в йэЬтоническом растворе хлорида натри  или в растворе новокаина, отличающийс  тем, Что, с целью повышени  активности целево100 20 25 . 100 100 го продукта, раствор обрабатывают пульсирующим магнитным полем напр жённостью 1800 ± 800 Э в течение 100 t 30 мин. Источники информации, прин тие во внимание при экспертизе 1. Машковский М.Д. Лекарственные с редс±ва. М., 1977, 11, С. 377Without MP treatment: 345 With pulsating MP processing with a tension: 1800 E 345 Claims of obtaining method of dissociating a solution of dry preyarata in sodium chloride sodium solution or in novocaine solution, characterized in that, in order to increase the activity of target 100 20 25. 100 100 of the product, the solution is treated with a pulsating magnetic field of 1800 ± 800 Oe for 100 t 30 min. Sources of information taken into account during the examination 1. Mashkovsky MD. Medicinal with red ± va. M., 1977, 11, p. 377
SU772553066A 1977-12-08 1977-12-08 Method of obtaining lysozyme solutions SU764679A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU772553066A SU764679A1 (en) 1977-12-08 1977-12-08 Method of obtaining lysozyme solutions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU772553066A SU764679A1 (en) 1977-12-08 1977-12-08 Method of obtaining lysozyme solutions

Publications (1)

Publication Number Publication Date
SU764679A1 true SU764679A1 (en) 1980-09-23

Family

ID=20737200

Family Applications (1)

Application Number Title Priority Date Filing Date
SU772553066A SU764679A1 (en) 1977-12-08 1977-12-08 Method of obtaining lysozyme solutions

Country Status (1)

Country Link
SU (1) SU764679A1 (en)

Similar Documents

Publication Publication Date Title
JPS56135418A (en) Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
DE3672868D1 (en) TREATMENT OF SOLID PHASED BIOLOGICAL AND PHARMACEUTICAL PRODUCTS WITH VIRUSES AND PYROGENS INACTIVATING AGENTS.
DE68917219T2 (en) Therapeutic product for the treatment of symptoms during or after the menopause.
RU93004764A (en) AMIDA SULFAMIDO-AND SULFAMIDOKARBONYLPYRIDIN-2-CARBIC ACIDS, THEIR Pyridine-N-OXIDES, METHOD OF THEIR RECEIVING AND THEIR APPLICATION AS MEDICINE PREPARATIONS
FI832355A0 (en) 9- (2-HYDROXYETOXIMETYL) guanidine derivate
EA199800690A1 (en) SUBSTITUTED N - [(AMINOIMINOMETHYL) PHENYLALKYL] AZHGETHROCYLAMIDE OF SULPHONIC ACIDS
ATE145136T1 (en) USE OF KETOCONAZOLE AND A RETINOID FOR THE TREATMENT OF ACNE VULGARIS
ES482097A1 (en) Novel acyl-derivatives of carnitine and process for their preparation
DE58901002D1 (en) AGENT WITH DESTROYING EFFECT ON MALIGNE TUMORS, METHOD FOR THE PRODUCTION THEREOF AND PREPARATION FOR USE IN THE THERAPY OF CANCER DISEASES.
ES8607916A1 (en) Biscarboxamides for treating diseases, and process for their preparation.
SU764679A1 (en) Method of obtaining lysozyme solutions
FR2659956B1 (en) PROCESS FOR TREATING AN AQUEOUS SOLUTION CONTAINING MAINLY NITRIC ACID AND FLUORHYDRIC ACID.
EA199800526A1 (en) DERIVATIVES OF BENZIMIDAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF VIRAL INFECTIONS
ATE27157T1 (en) CYCLOALKYL DERIVATIVES OF BENZISOSELENAZOLONES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
ATE109006T1 (en) PHARMACEUTICAL COMPOSITION INTENDED TO TREAT OR PREVENT RETROVIRAL INFECTIONS.
AU608545B2 (en) An improved method
DE3275060D1 (en) Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs
ATE86611T1 (en) TOPICAL PHARMACEUTICALS FOR THE TREATMENT OF ACNE AND SKIN DISEASES.
IT1136624B (en) COLIC ACID SALTIFICATION PRODUCTS, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS THAT INCLUDE THEM AS AN ACTIVE PRINCIPLE
DE68901172D1 (en) (-) - 2-PYRAZOLINE COMPOUND, THEIR OPTICAL UNLOCKING AND THERAPEUTIC AGENT FOR THE TREATMENT OF CEREBRAL VEGETABLE DISEASES, CONTAINING THIS COMPOUND AS AN ACTIVE INGREDIENT.
Baluda et al. The effects of administration of drugs influencing haemostasis during treatment of patients with burns
DE69126977D1 (en) Use of leukoregulin for the treatment of animals infected with an envelope virus
Chiu Rejuvenating effect of procaine: a critical review of reports
SU1221599A1 (en) Method of determining pharmacological activity of preparation
SU659563A1 (en) Aniline sulfosalicylate possessing antihelminthic activity